TVA Medical
- Company typePrivate
- Founded2008
- HeadquartersAustin, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
TVA Medical firmographics
Firmographics- Name
- TVA Medical
- Legal name
- Becton, Dickinson and Company
- Website
- https://tvamedical.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
TVA Medical industry classification
Industry- Product category
- Vascular Access Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories) (HLAHAKAE)
- akta.pro secondary industries
- Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK), Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)
Keywords
Where TVA Medical is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Markets served
TVA Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Others
Revenue model
- Medical Device Sales: Sale of the WavelinQ™ EndoAVF System consisting of 4F venous and arterial magnetic catheters, used with an electrosurgical unit (radiofrequency generator), ground pad, and electrosurgical pencil. Single-use catheters generate recurring revenue per procedure.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
TVA Medical product offering
Product offeringCore offering
TVA Medical developed the WavelinQ EndoAVF System, an endovascular medical device platform that creates arteriovenous fistulas (AVF) for hemodialysis vascular access without open surgery. The system consists of 4F venous and arterial magnetic catheters used with an electrosurgical unit (RF generator), ground pad, and electrosurgical pencil; magnetic alignment pulls adjacent artery and vein together while a burst of RF energy creates the fistula connection. The product is sold to hospitals, dialysis centers, and interventionalists for use in patients with end-stage kidney disease requiring hemodialysis.
Product overview
The WavelinQ™ EndoAVF System is a single medical device product for creating arteriovenous fistulas endovascularly. The system consists of 4F venous and 4F arterial magnetic catheters, used with an electrosurgical unit (radiofrequency generator), ground pad, and electrosurgical pencil. It represents a non-surgical alternative to traditional open surgery for AV fistula creation in ESKD patients requiring hemodialysis.
Differentiator
Problem solved
Functional benefit
Brands
- WavelinQ™ EndoAVF System: Endovascular arteriovenous fistula creation system for hemodialysis access in patients with end-stage kidney disease.
Products and services
- WavelinQ EndoAVF System
Quantifiable outcome
- 97% Procedure Technical Success Rate
- +2 more outcomes
Companies that use TVA Medical
Customer profileSegments3 records
Ideal customer profiles2 records
TVA Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
TVA Medical partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights3 records
TVA Medical competitors and assessment
Company assessmentDirect peers
- Medtronic: Medtronic markets the Ellipsys CVAC System, a direct competitor to WavelinQ for endovascular AV fistula creation in hemodialysis patients. Both companies target the same proceduralists and patient population with catheter-based, non-surgical AVF creation approaches.
- Teleflex: Teleflex manufactures vascular access catheters and related devices used in interventional procedures, including those performed by proceduralists using endovascular systems like WavelinQ. Overlap in endovascular catheter technology and customer base.
- AngioDynamics: AngioDynamics produces vascular access products including dialysis catheters and ports used in hemodialysis patients. Overlaps with TVA in vascular access for the ESKD patient population and catheter-based device delivery.
Broad incumbents
- Becton, Dickinson and Company (BD): BD acquired TVA Medical's technology through its acquisition of Bard and is the current owner and distributor of WavelinQ. As parent company and broad incumbent in vascular access and dialysis products, BD sets commercial strategy and competes against other major vascular access players.
- Baxter International: Baxter invested in TVA via Baxter Ventures and is a major incumbent in dialysis (renal therapies) and vascular access. Baxter's broad portfolio in chronic kidney disease treatment overlaps with the patient population TVA's WavelinQ serves.
- Boston Scientific: Boston Scientific invested in TVA's Series C and is a broad incumbent in interventional and vascular devices. While not a direct fistula-creation competitor, it operates in the same endovascular interventional space serving interventionalists who perform EndoAVF procedures.
- Fresenius Medical Care: Fresenius is the world's largest dialysis services provider and manufactures vascular access products. As the dominant buyer-side player in hemodialysis, Fresenius influences adoption of fistula creation technologies including EndoAVF.
- Abbott: Abbott operates broadly in vascular and interventional devices following its St. Jude Medical and Cephea acquisitions. Provides catheter-based vascular access and closure products serving interventionalists who also perform WavelinQ EndoAVF procedures.
Emerging players
- Penumbra: Penumbra is an emerging player in vascular intervention with catheter-based thrombectomy and access technologies. Operates in the same endovascular interventional space and serves some of the same proceduralist customers as WavelinQ.
- Surmodics: Surmodics develops surface coating technologies and drug-coated balloon catheters used in vascular procedures including dialysis access maintenance. Adjacent to TVA's vascular access focus with overlapping customer base of interventionalists.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
TVA Medical social profiles
Digital presenceTVA Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
TVA Medical leadership team
Management profileNumber of profiles
Profiles4 records
TVA Medical funding detail
Funding detailFunding overview
Funding rounds4 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TVA Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TVA Medical
What does TVA Medical do?
TVA Medical developed the WavelinQ EndoAVF System, an endovascular medical device platform that creates arteriovenous fistulas (AVF) for hemodialysis vascular access without open surgery. The system consists of 4F venous and arterial magnetic catheters used with an electrosurgical unit (RF generator), ground pad, and electrosurgical pencil; magnetic alignment pulls adjacent artery and vein together while a burst of RF energy creates the fistula connection. The product is sold to hospitals, dialysis centers, and interventionalists for use in patients with end-stage kidney disease requiring hemodialysis.
Is TVA Medical a public or private company?
TVA Medical is a private company. It is classified as corporate owned and is currently acquired.
When was TVA Medical founded?
TVA Medical was founded in 2008. It employs 11 to 50 people.
Where is TVA Medical based?
TVA Medical is headquartered in Austin, United States, in the North America region.
How does TVA Medical make money?
One revenue line is on record: medical Device Sales.
Who are TVA Medical's main competitors?
Direct peers on record are Medtronic, Teleflex and AngioDynamics. Broad incumbents are Becton, Dickinson and Company (BD), Baxter International, Boston Scientific, Fresenius Medical Care and Abbott. Emerging players are Penumbra and Surmodics.
Does TVA Medical have an API?
No public API is recorded for TVA Medical.
What industry is TVA Medical in?
TVA Medical's product category is Vascular Access Medical Devices. Its primary akta.pro industry code is HLAHAKAE, Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories), with a secondary code of HLAHAFAK, Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems). Its NAICS code is 334510 and its SIC code is 3845.